Focus: Microbot Medical develops micro-robot assisted medical technologies for minimally invasive endovascular interventions. The company is a publicly traded medical device biotechnology firm focused on peripheral vascular applications.
Profile data last refreshed 3h ago · AI intelligence enriched 2mo ago
No open roles listed right now. Follow Microbot Medical to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from Microbot Medical's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Microbot Medical
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Microbot Medical Inc (MBOT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Microbot Medical Inc (MBOT) Earnings Forecast: Future EPS & Revenue Growth Estimates TradingKey
MBOT|Microbot Medical Inc|Price:1.890|Chg%:+0.090 - TradingKey
MBOT|Microbot Medical Inc|Price:1.890|Chg%:+0.090 TradingKey
Microbot Medical Inc (MBOT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Microbot Medical Inc (MBOT) Earnings Forecast: Future EPS & Revenue Growth Estimates TradingKey
Microbot Medical CEO to Present Endovascular Robotics July 25 - stocktitan.net
Microbot Medical CEO to Present Endovascular Robotics July 25 stocktitan.net
Microbot Medical® Reports Over 100% Revenue and Customer Growth as Procedure Volume Also Rises in the Second Quarter of 2026 - GlobeNewswire
Microbot Medical® Reports Over 100% Revenue and Customer Growth as Procedure Volume Also Rises in the Second Quarter of 2026 GlobeNewswire
Microbot Medical taps Sanmina to manufacture Liberty system - AuntMinnie
Microbot Medical taps Sanmina to manufacture Liberty system AuntMinnie
Showing 6 of 10 news items
No open positions listed yet. Check their careers page directly.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moRecent peer-reviewed publications with author affiliations at this company